The short version
What teams need to understand
- Pharmacovigilance training must be delivered through defined and controlled methods.
- Completion of required training must be recorded and traceable at individual level.
- Training records must show what was delivered, when it was completed, how it was delivered, and who provided it.
- Evidence of attendance, completion, assessment, or certification must be retained where applicable.
- Training records must be complete, secure, and readily retrievable for audit or inspection.
- Inspection-ready evidence must demonstrate that required training was not only assigned, but actually completed and documented.
Regulatory expectation
What regulators expect
Each expectation should be supported by controlled documentation, traceable records, clear ownership, and evidence that the process works in practice.
- Training delivery must be documented.
- Completion of training must be traceable to the individual.
- Training records must show what was completed and when.
- Evidence of training completion must be retained.
- Training records must be available for audit and inspection.
Why it matters
What this means in practice
Inspectors assess whether pharmacovigilance training is delivered through controlled methods and supported by complete records. They review training logs, completion evidence, delivery methods, and whether the organisation can prove that required training was actually completed and retained in an audit-ready format.
Questions this page answers
Inspection evidence
Evidence teams should be able to show
Training Delivery Records
- Documented training sessions with topic, date, and trainer
- Defined delivery methods such as classroom, webinar, e-learning, or on-the-job training
- Attendance records for instructor-led sessions
- Evidence that training was delivered as planned
Training Record Log
- Employee name, department, and position
- Training title, training date, and completion date
- Training method and trainer or provider
- Certification or assessment outcome where applicable
- Comments on retakes, quiz scores, or exceptions
Completion and Assessment Evidence
- Signed attendance sheets or e-signatures
- Learning management system completion records
- Quiz or knowledge check results
- Certificates of completion for formal courses
Training Materials and Supporting Records
- Training slides, modules, or reference materials
- Version-controlled training content
- Linked evidence showing what content was delivered
- Archived copies of historical training materials where relevant
Record Retention and Retrieval Controls
- Secure storage of training records
- Defined retention periods for training documentation
- Ability to retrieve records by employee, role, or topic
- Audit-ready access to training evidence
Regulatory Basis (Primary Sources)
- GVP Module I - personnel performing PV activities must be trained and documented as competent
- GVP Module II - documentation must support operation of the PV system and inspection readiness
- ICH E2D - personnel handling safety data must be appropriately trained and supported by documented processes
- MHRA GPvP guidance - expectations for documented training records and competence evidence
- FDA 21 CFR Part 11 - electronic training records and evidence must be controlled and traceable where maintained electronically
Typical Inspection Questions (What Inspectors Ask)
- Show me the training records for this employee.
- How do you prove this training was completed?
- What method was used to deliver this training?
- Where are your training records stored?
- How quickly can you retrieve training evidence during an inspection?
Common failure patterns
What good looks like
- Complete and traceable training records for all required training.
- Clear evidence of training completion by individual.
- Documented delivery methods and trainer information.
- Assessment or certification records retained where applicable.
- Secure, audit-ready training records that can be retrieved quickly.
How teams operationalise it
- Use a controlled system or log to record all training completion.
- Capture employee identity, training topic, dates, method, and provider for each training activity.
- Retain completion evidence such as attendance records, LMS logs, or certificates.
- Store training materials and records in a secure and retrievable format.
- Verify that training evidence matches assigned training requirements.
- Review record completeness regularly as part of training governance.
From expectation to working control
Find the documentation that supports this work
Review the related toolkit to understand its purpose, included files, and how it supports this regulatory expectation.
Frequently asked questions
How is pharmacovigilance training documented?
Pharmacovigilance training is documented through training records that capture the employee, training topic, delivery method, training date, completion date, trainer, and any assessment or certification outcome.
What evidence is needed to prove training completion in pharmacovigilance?
Evidence may include signed attendance sheets, LMS completion records, quiz results, certificates, webinar logs, or other controlled records showing that the training was completed.
What should a PV training record include?
A PV training record should include the employee's identity, role, training title, delivery date, completion date, method of training, trainer or provider, and any certification or comments relevant to completion.
Do inspectors review pharmacovigilance training records?
Yes. Inspectors frequently review training records to confirm that required training was completed, documented properly, and linked to the individual's role.
How long should pharmacovigilance training records be kept?
Training records should be retained for the period defined in the company's document retention policy and any applicable regulatory requirements, while remaining secure and retrievable.
Why is training evidence important in pharmacovigilance?
Training evidence is important because it proves that personnel were trained and competent to perform PV activities, which is a core expectation during audits and inspections.
Source boundary
Regulatory sources
These primary sources inform this structured interpretation. Always confirm current requirements against the original source and the requirements applicable to your organisation, product, and jurisdiction.
European Medicines Agency (EMA)
Guideline on good pharmacovigilance practices (GVP) - Module I
View sourceGuideline on good pharmacovigilance practices (GVP) - Module II
View source
FDA
21 CFR Part 11 - Electronic Records
View source
ICH
Post-Approval Safety Data Management (E2D)
View source
MHRA
Good Pharmacovigilance Practice (GPvP)
View source